↓ Skip to main content

MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic…

Overview of attention for article published in Breast Cancer Research, February 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
57 Mendeley